{"id":"W3171624023","doi":"10.1007/s00277-021-04545-5","title":"Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial","year":2021,"lang":"en","type":"erratum","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Cytarabine; Internal medicine; Myeloid leukemia; Hematology; Oncology; Term (time); Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00926357,0.002337123,0.002800095,0.003261341,0.002218362,0.005321766,0.003928373,0.006724302,0.07504771],"category_scores_gemma":[0.1005128,0.001417131,0.002751889,0.003008072,0.002166801,0.002011723,0.001465557,0.01372209,0.03607066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004788057,"about_ca_system_score_gemma":0.008175179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009423372,"about_ca_topic_score_gemma":0.01249921,"domain_scores_codex":[0.9920377,0.002049871,0.001466276,0.0008613371,0.002952558,0.0006322197],"domain_scores_gemma":[0.936033,0.02490941,0.004103319,0.002875999,0.02834199,0.003736321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009153607,0.000007345593,0.00004354857,0.0001936976,0.0000219974,0.00006832974,0.000008063078,0.00003324328,0.00002446367,0.0002072679,0.995584,0.003716501],"study_design_scores_gemma":[0.0006997559,0.00009062178,0.001212487,0.001162144,0.0001497803,0.0005203272,0.00004703074,0.0003821248,0.0003863492,0.00163881,0.993647,0.00006351775],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0001049351,0.001223228,0.0004482763,0.05580737,0.93828,0.00005016281,0.002145349,0.000253564,0.001687201],"genre_scores_gemma":[0.009872803,0.01073271,0.005474003,0.1743915,0.649379,0.0006496882,0.006115466,0.001991836,0.141393],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.07504771,"threshold_uncertainty_score":0.2510596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03008883412672299,"score_gpt":0.3805823575140232,"score_spread":0.3504935233873002,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}